Published in TB and Outbreaks Week, October 7th, 1996
A U.S. Centers for Disease Control and Prevention (CDC) study found that 1.5 percent of TB cases reported in New York City between 1993 and 1994 were mono-rifampin resistant.
The study was outlined in a poster presentation at the 36th Meeting of the American Society for Microbiology's Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC), held September 15-18, 1996 in New Orleans, Louisiana.
There were 99 cases of...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of TB and Outbreaks Week